Booking Holdings Inc. (BKNG) vs United Therapeutics Corporation (UTHR)
A side-by-side comparison of Booking Holdings Inc. and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.
Different business models: BKNG is classified in Consumer Cyclical; UTHR is classified in Healthcare. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
BKNG
Booking Holdings Inc.
$173.92Consumer CyclicalDelayed quote: Sep 11, 2026, 4:00 PM EDT
UTHR
United Therapeutics Corporation
$497.11HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
Total return — BKNG vs UTHR
growth of $100 · dividends reinvested · last 10yBKNG +218.8% (+12.3%/yr)UTHR +312.8% (+15.2%/yr)UTHR compounded faster over this window
BKNG UTHR
BKNG vs UTHR: by the numbers
- •BKNG is the larger company ($134.77B vs $21.10B market cap).
- •UTHR trades at the lower trailing earnings multiple (17.81 vs 19.29 P/E), one valuation lens rather than an overall verdict.
- •UTHR converts more revenue to profit (41.56% vs 25.53% net margin).
- •BKNG grew revenue faster over the past five years (31.52% vs 14.68% CAGR).
- •BKNG pays a dividend (0.92% yield), while UTHR has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BKNG | UTHR |
|---|---|---|
| P/E ratio | 19.29 | 17.81 |
| Forward P/E | 16.64 | 19.01 |
| P/S ratio | 4.77 | 6.69 |
| P/B ratio | N/A | 3.30 |
| EV / EBITDA | 13.30 | 12.91 |
| FCF yield | 7.08% | 5.18% |
Profitability
| Metric | BKNG | UTHR |
|---|---|---|
| Gross margin | 100.00% | 86.14% |
| Operating margin | 34.49% | 44.49% |
| Net margin | 25.53% | 41.56% |
| ROE | N/A | 20.48% |
| ROIC | 71.23% | 17.69% |
Dividends
| Metric | BKNG | UTHR |
|---|---|---|
| Dividend yield | 0.92% | N/A |
| Payout ratio | 17.83% | N/A |
Growth (annualized)
| Metric | BKNG | UTHR |
|---|---|---|
| Revenue CAGR (5Y) | 31.52% | 14.68% |
| EPS CAGR (5Y) | 158.62% | 20.93% |
| FCF CAGR (5Y) | 56.15% | 14.31% |
| Total return CAGR (5Y) | 14.07% | 19.17% |
Frequently asked
- Which has the lower trailing P/E, BKNG or UTHR?
- UTHR has the lower trailing P/E: BKNG trades at 19.29 and UTHR at 17.81. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, BKNG or UTHR?
- Over the past five years, BKNG grew revenue faster — BKNG at a 31.52% CAGR versus UTHR at 14.68%.
- Does BKNG or UTHR pay a bigger dividend?
- BKNG pays a dividend (0.92% yield), while UTHR has no payments in the available dividend history.
- Is BKNG or UTHR more profitable?
- UTHR runs the higher net margin — BKNG at 25.53% versus UTHR at 41.56%.
- How have BKNG and UTHR total returns compared?
- Over the past 10 years, BKNG delivered 12.15% and UTHR delivered 15.50% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Booking P/E ratioUnited Therapeutics P/E ratioBooking dividend yieldBooking ROEUnited Therapeutics ROEBooking operating marginUnited Therapeutics operating marginBooking revenue growthUnited Therapeutics revenue growthBooking free cash flowUnited Therapeutics free cash flow
Booking & United Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.